Esperion Therapeutics (ESPR) – Analysts’ Recent Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of Esperion Therapeutics (NASDAQ: ESPR) in the last few weeks: 12/18/2024 – Esperion Therapeutics is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “neutral” rating and a $4.00 price target on the stock. 12/17/2024 – Esperion Therapeutics is now […]
More Stories
Stria Lithium (CVE:SRA) Share Price Passes Below 200-Day Moving Average – Here’s What Happened
Stria Lithium Inc. (CVE:SRA – Get Free Report)’s share price crossed below its 200-day moving average during trading on Thursday...
Congress Prepares to Certify Trump’s Election Victory on Jan. 6
By Tom Ozimek Congress will hold a joint session on Jan. 6 to count the Electoral College votes, marking the...
Omineca Mining and Metals (CVE:OMM) Stock Price Down 14.3% – What’s Next?
Omineca Mining and Metals Ltd. (CVE:OMM – Get Free Report) shares dropped 14.3% during mid-day trading on Saturday . The...
Stalled Minnesota Copper-Nickel Mine Could Break Ground With Trump Back in White House
By John Haughey A fiercely contested Minnesota copper-nickel mining proposal is among stymied mineral and energy development projects President-elect Donald...
Falcon Oil & Gas (CVE:FO) Share Price Crosses Below Fifty Day Moving Average – Here’s Why
Shares of Falcon Oil & Gas Ltd. (CVE:FO – Get Free Report) passed below its 50-day moving average during trading...
JBS (OTCMKTS:JBSAY) Shares Pass Below Fifty Day Moving Average – Should You Sell?
Shares of Jbs S.A. (OTCMKTS:JBSAY – Get Free Report) crossed below its 50-day moving average during trading on Thursday ....